115.29
price down icon1.81%   -1.96
 
loading

Celcuity Inc Borsa (CELC) Ultime notizie

pulisher
03:33 AM

Celcuity (CELC) Is Up 11.3% After FDA Grants Priority Review To Gedatolisib NDAWhat's Changed - simplywall.st

03:33 AM
pulisher
Jan 27, 2026

Celcuity (NASDAQ:CELC) Reaches New 52-Week HighTime to Buy? - MarketBeat

Jan 27, 2026
pulisher
Jan 27, 2026

Celcuity stock hits all-time high at 116.65 USD - Investing.com

Jan 27, 2026
pulisher
Jan 27, 2026

Celcuity Inc. Earnings Call: Strong Progress Amid Challenges - MSN

Jan 27, 2026
pulisher
Jan 25, 2026

Celcuity, Inc. (NASDAQ:CELC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Jan 25, 2026
pulisher
Jan 23, 2026

Celcuity Inc: A Die To Be Cast Before July 2026 (NASDAQ: CELC) - Seeking Alpha

Jan 23, 2026
pulisher
Jan 23, 2026

Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator’s Growth Potential - DirectorsTalk Interviews

Jan 23, 2026
pulisher
Jan 21, 2026

Reassessing Celcuity (CELC) Valuation After A 51.85% Three Month Share Price Gain - Yahoo Finance

Jan 21, 2026
pulisher
Jan 21, 2026

(CELC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Jan 21, 2026
pulisher
Jan 21, 2026

FDA accepts Celcuity’s NDA for gedatolisib with priority review By Investing.com - Investing.com South Africa

Jan 21, 2026
pulisher
Jan 20, 2026

Celcuity granted FDA priority review for breast cancer therapy - MSN

Jan 20, 2026
pulisher
Jan 20, 2026

Celcuity wins FDA review for breast cancer drug (CELC:NASDAQ) - Seeking Alpha

Jan 20, 2026
pulisher
Jan 20, 2026

FDA Accepts Celcuity's NDA For Gedatolisib In HR+, HER2- Advanced Breast Cancer - Nasdaq

Jan 20, 2026
pulisher
Jan 20, 2026

FDA accepts Celcuity’s NDA for gedatolisib with priority review - Investing.com

Jan 20, 2026
pulisher
Jan 20, 2026

Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer - manilatimes.net

Jan 20, 2026
pulisher
Jan 19, 2026

Short Interest in Celcuity, Inc. (NASDAQ:CELC) Expands By 20.9% - MarketBeat

Jan 19, 2026
pulisher
Jan 19, 2026

Is Celcuity Inc. stock gaining market shareEarnings Growth Summary & Daily Profit Maximizing Trade Tips - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 17, 2026

Dow Update: Can POAI lead its sector in growth2025 Valuation Update & Long-Term Safe Investment Ideas - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 17, 2026

Merger Talk: Is Madison Square Garden Sports Corp stock forming a cup and handleJuly 2025 Rallies & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 16, 2026

Chart Watch: Can Celcuity Inc disrupt its industryJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 16, 2026

Nisa Investment Advisors LLC Buys 14,930 Shares of Celcuity, Inc. $CELC - MarketBeat

Jan 16, 2026
pulisher
Jan 15, 2026

Celcuity (NASDAQ:CELC) Shares Down 6.2%Should You Sell? - MarketBeat

Jan 15, 2026
pulisher
Jan 15, 2026

This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why - MSN

Jan 15, 2026
pulisher
Jan 15, 2026

Celcuity stock reaches all-time high at 112.78 USD By Investing.com - Investing.com Nigeria

Jan 15, 2026
pulisher
Jan 14, 2026

Celcuity (NASDAQ:CELC) Reaches New 1-Year HighStill a Buy? - MarketBeat

Jan 14, 2026
pulisher
Jan 14, 2026

Celcuity stock reaches all-time high at 112.78 USD - Investing.com

Jan 14, 2026
pulisher
Jan 14, 2026

Market Wrap: Can Celcuity Inc ride the EV waveJuly 2025 Closing Moves & Short-Term High Return Ideas - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 13, 2026

Macro Review: Can Celcuity Inc. stock beat analyst upgrades2025 Volume Leaders & Growth-Oriented Investment Plans - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

The Bull Case For Celcuity (CELC) Could Change Following Shelf Registration And FDA Review ProgressLearn Why - simplywall.st

Jan 13, 2026
pulisher
Jan 12, 2026

Celcuity (NASDAQ:CELC) Shares Gap DownHere's What Happened - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Wells Fargo initiates coverage on Celcuity Inc. (CELC) - MSN

Jan 12, 2026
pulisher
Jan 11, 2026

Assessing Celcuity (CELC) Valuation After Wells Fargo Coverage And Key FDA NDA Review Progress - simplywall.st

Jan 11, 2026
pulisher
Jan 11, 2026

Wells Fargo Initiates Coverage On Celcuity Inc. (CELC) - Finviz

Jan 11, 2026
pulisher
Jan 10, 2026

Celcuity (CELC) surges 662% in 2025 on breast cancer treatment trial results - MSN

Jan 10, 2026
pulisher
Jan 10, 2026

How (CELC) Movements Inform Risk Allocation Models - Stock Traders Daily

Jan 10, 2026
pulisher
Jan 10, 2026

Risks Report: Is American National Group Inc stock attractive for long term wealth buildingMarket Sentiment Report & Trade Opportunity Analysis Reports - moha.gov.vn

Jan 10, 2026
pulisher
Jan 09, 2026

Celcuity files for mixed shelf size not disclosedSEC filing - marketscreener.com

Jan 09, 2026
pulisher
Jan 09, 2026

Celcuity Inc. (CELC) Investor Outlook: Analyzing the Biotechnology Stock with a $4.84 Billion Market Cap - DirectorsTalk Interviews

Jan 09, 2026
pulisher
Jan 09, 2026

Why Celcuity Inc. stock is a value investor pickJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Can Celcuity Inc. stock beat analyst upgradesJuly 2025 Review & Precise Swing Trade Entry Alerts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire

Jan 08, 2026
pulisher
Jan 08, 2026

Is Celcuity Inc. stock attractive after correction2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - ulpravda.ru

Jan 08, 2026
pulisher
Jan 07, 2026

Gains Recap: Can Celcuity Inc stock sustain free cash flow growthMarket Sentiment Review & AI Enhanced Market Trend Forecasts - moha.gov.vn

Jan 07, 2026
pulisher
Jan 07, 2026

What valuation multiples suggest for Celcuity Inc. stockMean Reversion Trades & Exceptional Profit Growth - ulpravda.ru

Jan 07, 2026
pulisher
Jan 06, 2026

Celcuity initiated with an Outperform at Wolfe Research - MSN

Jan 06, 2026
pulisher
Jan 06, 2026

Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase? - The Globe and Mail

Jan 06, 2026
pulisher
Jan 06, 2026

2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue - MSN

Jan 06, 2026
pulisher
Jan 06, 2026

Analysts Expect Breakeven For Celcuity Inc. (NASDAQ:CELC) Before Long - 富途牛牛

Jan 06, 2026
pulisher
Jan 05, 2026

What analysts say about Celcuity Inc stockWeekly Market Snapshot & You’ll Thank Yourself in 6 Months - earlytimes.in

Jan 05, 2026
$98.58
price down icon 1.31%
$101.14
price down icon 2.34%
$32.91
price down icon 4.30%
$115.00
price down icon 3.63%
$160.48
price down icon 1.20%
biotechnology ONC
$347.98
price up icon 3.45%
Capitalizzazione:     |  Volume (24 ore):